Health outcome priorities of people with multiple long-term conditions before and during the COVID-19 pandemic: Survey data from the UK

INTRODUCTION

Finding ways to improve the management of people with multiple long-term conditions (MLTC), also known as multimorbidity (1), is now a global priority for policy and healthcare research (2). The delivery of person-centred care, with the incorporation of patients’ priorities and preferences into decision-making, is key to the effective management of people with MLTC (3). The National Institute of Health and Care Excellence (NICE) highlights the inclusion of patient’s priorities, values and goals, in their quality standards for the management of people with MLTC. One previous systematic review showed there were major differences in the processes of prioritisation of people with MLTC and from the clinicians who were managing people with MLTC, thus highlighting the need to elicit the priorities of people with MLTC in each consultation, to avoid the risk of a misalignment of priorities (4). The review also found large variations in how priorities were ascertained, along with the tools used for this purpose, and we emphasised the need for a standardised tool to facilitate clinicians in eliciting the priorities of patients with MLTC (4).

The outcome prioritisation tool (OPT) previously developed by Fried et al, emerged as the most commonly used validated tool to date in our systematic review (4, 5). The OPT is a simple tool to facilitate clinicians in ascertaining the health outcome priorities of their patients across four domains, namely: maintaining independence, keeping alive, reducing pain, or reducing other symptoms (5). The feasibility of using the OPT to elicit the priorities of people with MLTC aged 65 years and over (5, 6), to facilitate medication review (7, 8), and complex treatment decision-making in older people with MLTC (9), has previously been investigated in clinical settings in the United States and in the Netherlands. However, this tool is yet to be applied to a population in the United Kingdom (UK), to younger people aged under 65 years or to an ethnically diverse population. Whilst a higher proportion of older adults suffer from MLTC (10), the prevalence of MLTC in younger adults is also high and continuing to rise (11). Ethnicity-based differences in the risk of diagnoses of MLTC have also been found, with people of Asian ethnicity at increased risk of suffering from MLTC (12). However there has been very little understanding of the health outcome priorities of people with MLTC aged under 65, and/or people with MLTC from ethnic minority backgrounds, and how their health outcome priorities can be elicited. Moreover, the COVID-19 pandemic raised further challenges for people with MLTC, as the presence of MLTC is an independent risk factor for an increased risk of severe COVID-19 and mortality (13,14).

Therefore, the aims of this study were to describe the health outcome priorities of multi-ethnic people with MLTC including those aged 65 years and under, investigate the association between patient’s current first-choice health priority and risk factors, compare the health outcome priorities of patients before the onset of the COVID-19 outbreak to their current health outcome priorities. A further aim was, to examine the feasibility of the validated OPT by patient-reported relevance, ease of use, and patient-perceived usefulness.

METHODS

RESULTS

Summary of health outcome priority scores

In the whole cohort (N=2,454), the health outcome of keeping alive was the highest priority with the median value of 98 [IQR 88 - 100], followed by maintaining independence (97 [85 - 100]), reducing pain (92 [77 - 99]), and reducing other symptoms (87 [74 - 99]), Figure 1.

• Download figure
• Open in new tab

Figure 1. Health outcome priority score in the whole cohort

Reference line represents the median value of health prioritisation on the scale of 0 to 100. Median [interquartile range]: maintaining independence 97 [85 - 100], keeping alive 98 [88 - 100], reducing pain 92 [77 - 99], reducing other symptoms 87 [74 - 99].

Missing outcome: maintaining independence 140, keeping alive 164, reducing pain 221, reducing other symptoms 269.

Analysis of first-choice health outcome priority

Current first-choice health outcome priority

In the cohort of participants who did apply the trade-off principle, (n=884), keeping alive was the outcome top-ranked as first-choice (44%), next was maintaining independence (33%), then reducing pain (14%), and reducing other symptoms (10%), Table S3. When comparing by the respondent’s sociodemographic factors and clusters of conditions, we found statistically significant differences between most groups, Table S3. This was further illustrated by the significant associations (Table S4, Table S5, Figure 2). Maintaining independence was highly prioritised for those aged 65 years or more (adjusted OR 1.55 (95% CI 1.16, 2.06)) compared to aged 45-65 years; with higher education (2.27 (1.60, 4.14)), or secondary/further education (1.73 (1.11, 2.71)), compared with no education; and those at high risk of COVID-19 (1.60 (1.15, 2.21)). Male respondents were 37% more likely to prioritise keeping alive compared to females (1.37 (1.04, 1.80)).

• Download figure
• Open in new tab

Figure 2. Association between patient’s first-choice health priority and sociodemographic factors and clusters of long-term conditions

Models are adjusted by age (continuous) and gender (female or male).

CI=confidence interval.

Odds ratio <1 indicates low health priority, whereas odds ratio >1 indicate high health priority.

Bold indicates statistical significance, P<0.05.

Respondents who were unemployed prioritised reducing other symptoms three times more than those working (3.07 (1.48, 6.38), and reducing pain two times more [(2.41 (1.23, 4.69), and least prioritised keeping alive (0.40 (0.23, 0.69)). For those with musculoskeletal or chronic pain, their first-choice priority was reducing pain (1.65 (1.09, 2.50), and their least priority was maintaining independence (0.74, (0.55, 1.00)). While respondents who reported mental health conditions prioritised reducing other symptoms (1.62 (1.02, 2.57)), and least prioritised keeping alive (0.71 (0.52, 0.95)). Comparison by respondents’ ethnicity did not reveal any statistically significant differences in prioritisation Table S5, Figure 2.

Comparing the first-choice health outcome priorities before COVID-19 to current

From a “before COVID-19” perspective the outcome most frequently ranked as the first-choice was keeping alive (38%), next maintaining independence (34%), then reducing pain (18%), and reducing other symptoms (10%), Table S6. There were no significant differences in health outcome priority before COVID-19 and current using the continuous scores, further evidenced in Figure S2 and Figure S3.

DISCUSSION

Our study describes the health outcome priorities of a large cohort of participants and compares the health outcome priorities by age, clusters of long-term conditions, ethnicity and demographic factors. To our knowledge, this is the largest study to investigate the use of the OPT in people with MLTC, the first study to investigate the use of the OPT in the UK, in a multi-ethnic population, and in people with MLTC aged under 65. This is also the first study to compare the health outcome priorities of middle-aged people with MLTC (aged 45 to 65) and older people with MLTC (aged over 65), and whether the health outcome priorities of people with MLTC have changed in light of the COVID-19 pandemic. This study has made a novel contribution to understanding the health outcome priorities of people with MLTC and the factors that may influence them. This is a step towards facilitating the development of priorities-based models of care for people with MLTC.

With a mean participant age of 64 years, the cohort in our study can be considered to be representative of middle-aged people (18) with MLTC. The majority of participants agreed or strongly agreed that the OPT was easy to complete, relevant to their healthcare and will be useful in communicating priorities to their doctor. Hence, the results show that the OPT is relevant, useful, and easy to complete for middle-aged people with MLTC.

Overall, we found keeping alive was most frequently ranked as the first-choice health outcome priority, with maintaining independence being second most likely to be ranked as the top priority. Previous studies using the OPT in people with MLTC with sample sizes ranging from 59 to 357, have found that maintaining independence was most frequently ranked as the top priority (5, 8, 19) (7). This difference from our overall findings could be due to the fact that previous studies using the OPT have all focused on older people with MLTC, whereas we included middle-aged people with MLTC in our cohort. Indeed, comparison of participants’ ranking by age, revealed that participants aged over 65 were most likely to rank maintaining Independence as their top priority, and were more likely to do so than participants age under 65 years, which is in keeping with the findings of previous literature (5, 8, 19).

This age-based difference in the choice of first-choice health outcome priority in our findings further demonstrates that age may influence how people with MLTC prioritise their health outcomes. A previous systematic review also demonstrated age-based differences in how clinicians arrived at health outcome and treatment priorities for people with MLTC, as some clinicians reported that prioritising reduced the risk of mortality more highly as they felt they could be “more aggressive” in their clinical management, in people with MLTC aged under 65 (4).

We also observed statistically significant differences in participants’ priorities based on types of long-term conditions. Participants with musculoskeletal conditions or chronic pain were most likely to choose reducing pain as their first-choice health outcome priority. Previous literature has demonstrated that the empirical impact of illnesses including their symptom burden (4), and disease burden (20), were factors which influenced how people with MLTC chose priorities related to their health, and could provide the likely explanation for this finding, as the symptom of pain has the potential to form a significant part of the symptom burden experienced by people with musculoskeletal conditions (21), and/or chronic pain. Participants with mental health conditions were most likely to choose reducing other symptoms as their top priority, and keeping alive the least, which suggests that for these participants, their health outcome priorities could be related to the symptom burden of their illness but these were not available as a choice to be captured on the OPT.

We also found that socio-economic factors such as education and employment status were associated with statistically significant differences in prioritisation. Adjusting for age and gender, our results indicated that participants who were unemployed were three times more likely to prioritise reducing other symptoms, and twice more likely to prioritise reducing pain. Prolonged unemployment has previously been found to be associated with musculoskeletal pain (22). A previous study in the context of multiple sclerosis found that the presence of pain was associated with a reduced rate of employment (23), and another study investigating the impact of pain on employment amongst cancer survivors found that pain was associated with an increased risk of adverse employment outcomes (24). Our findings demonstrate that socio-economic factors can have an impact on the health outcome priorities of people with MLTC, and highlight the importance of taking a holistic person-centred approach that considers the impact of the socio-economic background of people with MLTC on an individual basis when eliciting their health outcome priorities in consultations.

We did not observe any statistically significant changes in participants’ reporting of their health outcome prioritisation from before the COVID-19 pandemic and currently. However, these results are subject to recall bias, as participants were asked to retrospectively report their health outcome priorities from before the onset of COVID-19.

The OPT has previously been used in a face-to-face format, where participants were helped by facilitators to indicate their order of prioritisation (5). However, in this study, the OPT was disseminated in an online questionnaire format in light of the COVID-19 pandemic, and whilst participants were advised in the participant information sheet to contact their practice or the study team if they had any questions regarding the study, direct facilitation to help patients complete the OPT was not feasible. We found that a significant number of participants (64%) gave the same scores to multiple domains or missed outcomes, raising the possibility that the “trade-off” principle with using the OPT may not have been clearly understood by participants on these occasions. The online format of the questionnaire, without the input of a facilitator or clinician, could have been a contributing factor to this.

The fact that participants were being asked to consider their priorities outside of a situation where there was an actual decision to be made rather than a hypothetical one, could also have been a contributing factor to this. Indeed, a previous study investigating the use of the OPT for medication review for older people (aged 69 years or above) with MLTC found that participants reported engaging with prioritisation to be “difficult when there was no specific need to make a decision” (7).

We suggest that the OPT could be sent remotely to people with MLTC’s to complete ahead of their consultations, with their responses being reviewed again with their clinicians during their consultations to clarify that the trade-off principle has been applied, and the responses being revisited at any point where there is a management or treatment decision to be made. This approach would provide people with MLTC’s with time and opportunity to consider their health outcome priorities ahead of their appointments and discuss these with their clinicians during their appointments, which could promote the efficacy and efficiency of prioritised-based consulting and are, in primary care settings.

STRENGTHS AND LIMITATIONS

To our knowledge, this was the first large study to implement the OPT in a UK setting, and the first to implement the OPT in participants from a multi-ethnic population aged under 65 years. With participation from multiple primary care practices across the East-midlands, and with a participant cohort representative of middle-aged and older people with MLTC, our study findings have demonstrated that people with MLTC found the OPT easy to use, relevant to their healthcare and perceive it to be useful in communicating their health outcome priorities to their doctor. Therefore, we found that this simple tool is acceptable to people with MLTC aged 45 years or above, and can feasibly be used in a primary care setting in future interventions to facilitate priorities-based care for people with MLTC in a primary care setting.

However, there are noteworthy limitations. As this was a cross-sectional study conducted after the onset of the COVID-19 pandemic, participants’ responses regarding their health outcome priorities prior to the COVID-19 pandemic were retrospective and hence subject to recall bias. We also found that a significant number of participants assigned the same scores to multiple health outcomes, suggesting that the “trade-off” principle was not always understood by participants, which could have been due to the virtual format of the questionnaire and the absence of a facilitator. The need to assign a score to each health outcome as part of the tool could also potentially lead to confusion regarding the trade-off principle.

Despite the study being set in a multi-ethnic setting with recruitment of primary care practices with high levels of ethnic diversity amongst their practice populations, we noted that there was a relatively low uptake of participation in our study from participants from ethnic minority backgrounds, with 92% of participants being of White ethnicity, and lower proportions of ethnic diversity amongst participants compared to National and Regional demographic data (25). A possible explanation for this could be due to a language barrier, as the invitation to participate in the study, and the study questionnaire itself were not available in any other languages besides English at this stage.

RECOMMENDATIONS FOR THE FUTURE

To reduce the risk of confusion in assigning scores to different health outcomes and facilitate participants in applying the trade-off principle to reflect a hierarchy of health outcomes in order of importance to them on an individual basis, we propose a re-design of the OPT in which participants are asked to place each health outcome into four coloured boxes in order of their individual importance to them (Figure 3). We propose that this redesign would clearly capture the rank assigned to each health outcome by the participant and mitigate the potential for confusion through the removal of a need for participants to assign a score. We also recommend translating the OPT into different languages to address any potential language barrier for people with MLTC completing the OPT. Additionally, we suggest that the OPT could be used remotely ahead of consultations with people with MLTC, with review of responses during the consultation to clarify that the trade-off principle has been applied, and incorporation into the consultation to facilitate priorities-based and person-centred management.

• Download figure
• Open in new tab

Figure 3. Health outcome prioritisation tool simplified for clinical use

Health outcome prioritisation tool developed by Fried et al (4).

CONCLUSION

As a simple tool that encourages people with MLTC to consider and record what is important to them in terms of their health outcomes, we found the OPT is simple and acceptable by people with MLTC and has the potential to be a valuable means to introduce and incorporate individual priorities into their clinical consultations and facilitate person-centred, priorities-based care planning. We also found that the health outcome priorities of people with MLTC can be influenced by a number of factors individual to each patient such as age, types of long-term conditions, and employment status. We therefore recommend that in their consultations with people with MLTC, clinicians should take a holistic approach that takes the potential impact of all of these factors into account, in the planning and provision of priorities-based care for people with MLTC.

DECLARATIONS

Ethical approval

NHS Ethical approval for this study was granted by the Riverside REC Committee (Reference:20/LO/0570).

Author Contribution

Conceptualization: HS, KK, SS Study design: HS, KK, SS Data preparation: HS, YC Data analysis: HS, YC, FZ, AR First draft: HS, YC, KK, SS Study critical revision and manuscript draft: All authors.

All authors provided final approval of the version to publish.

HS had full access to all the data in the study and had final responsibility for the decision to submit it for publication.

Funding

Dr Sathanapally and Dr Chudasama are supported by the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests

KK is national MLTC lead for NIHR Applied Research Collaboration and Co-led for the MLTC Cross NIHR Collaboration.